Rating History for Ovid Therapeutics Inc (OVID) by Roth/MKM
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 3/19/2026 | Boobalan Pachaiyappan | Maintain | Buy (N/A) |
5.00 (3.00) |
|
Details | |
![]() |
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 3/19/2026 | Boobalan Pachaiyappan | Maintain | Buy (N/A) |
5.00 (3.00) |
|
Details | |
![]() |
|||||||